Prakash Gudsoorkar
@gudnephron.bsky.social
Asso Prof UCCOM I Kidneydoc | @UCKidney Lead, OncoNeph Program ❤️ Onconeph, 🏡 dialysis, ICU Neph Deputy Editor @KidneyNews Editorial Board @akdhjounal @BMCNephro ⭐️wars 🤓 Fav 🏞️ : Grand Tetons 🐶🐾🦴 Dad 🇮🇳 ~> 🇨🇦 ~> 🇺🇸
This #ASNKidneyNews special section on green nephrology brings together insights from experts advocating responsible innovation in kidney care, balancing clinical efficacy with ecological stewardship. Explore the articles: bit.ly/KN-Green @gudnephron.bsky.social
We check renin in all patients refd to the Ottawa hypertension clinic (also 24 hour urine for Na & K) Renin phenotyping is useful - see data from @anandvaidya17.bsky.social in @ahajournals.bsky.social below
haysamrady@sodatroubles.bsky.social · last yr.ACE Inhibition to Distinguish Low-Renin Hypertension From Primary Aldosteronism #nephsky www.ahajournals.org/doi/10.1161/...
Oral health is often overlooked in nephrology care, despite significant implications. Authors unveil the crosstalk between oral and kidney health. bit.ly/KN1703-18 @gudspri.bsky.social @sujayamehta.bsky.social @gudnephron.bsky.social #ASNKidneyNews
What are some of the common and rare indications and complications of therapeutic plasma exchange? Find out in our new study published in BMC Nephrology! 🩸https://bmcnephrol.biomedcentral.com/articles/10.1186/s12882-025-03970-2#citeas @gudnephron.bsky.social #NephSky #MedStudentSky
www.nature.com/articles/s41... Can someone please share this article's PDF?
Interplay between periodontitis and chronic kidney disease - Nature Reviews Nephrology
Periodontal disease is very common and might represent a non-traditional risk factor for chronic kidney disease (CKD), independently of shared risk factors. Here, the authors discuss the interplay bet...
nature.com
Interested in Green Nephrology? Brand new paper from 🇪🇸out in CKJ on how to reduce the environmental footprint of dialysis, a “power- and water-hungry, and a waste generating intervention” academic.oup.com/ckj/advance-...
How to improve the environmental impact in hemodialysis: small actions, big changes
AbstractBackground and hypothesis. The burden of chronic kidney disease is increasing driven by population aging and the rising of risk factors. In-centre
academic.oup.com
even the @theisn.org #ISNWCN has two high impact trial sessions! This has to be one of the #TopNephrology stories the era of nephrology lagging behind in RCTs is over #NephSky
RBC cast - brightfield with SM stain - from patient admitted with AKI, "pneumonia" and fatigue - serologies all negative - biopsy pending ... #UrineMicroscopy #UrinarySediment
jamanetwork.com/journals/jam... GLP-1 RAs may reduce the risk of cirrhosis progression and complications in patients with MASLD and DM, especially when started early. No benefit observed if initiated after cirrhosis onset. #LiverHealth #DiabetesCare #metabolicsyndrome
GLP-1 Receptor Agonists and Cirrhosis in Metabolic Dysfunction-Associated Steatotic Liver Disease
This cohort study aims to determine whether use of glucagon-like peptide 1 receptor agonists are associated with lower risk of developing cirrhosis and its complications, including decompensation and ...
jamanetwork.com
Wondering why vasoconstrictors work in hepatorenal syndrome even though the pathogenesis is driven by renal vasoconstriction? Here is a conceptual explanation:
I am at the beginning of my AI journey of discovery, you know the place where you are still dumbfounded by what the machine can do. In this case it developed a pretty compelling electrolyte curriculum for nephrology fellows 😳 pbfluids.com/2024/11/ai-c...
AI Curriculum
I am still in the “amazed by what AI can do” stage Here is me prompt i am teaching a class on electrolyte abnormalities for nephrologists. What would be good tricky things to teach I th…
pbfluids.com
FINEARTS-HF trial in JAMA Cardiology: Finerenone was effective in reducing the risk of CV death and heart failure events even in patients with mildly reduced or preserved ejection fraction who experienced elevated potassium levels. #AHA24 https://ja.ma/4euKMwg
Transition from an estimated glomerular filtration rate (eGFR)-based to a risk-based approach to CKD care from KDIGO #Nephpearls #NephSky 👉 kdigo.org/guidelines/c... 💻 kidneyfailurerisk.com
x.com/tony_breu/st... Why iodine is used as IV contrast? Find this excellent Xorial by @tonybreu.bsky.social @zacharysmithmd.bsky.social @drjakenysather.bsky.social @jayminbpmd.bsky.social
x.com
x.com
The discovery of the #aquaporin #AQP family of water channels has provided a molecular counterpart to the movement of water across biological membranes. This JASN review, discusses the concept of osmosis and its central relevance for #PeritonealDialysis. journals.lww.com/jasn/fulltex...
Aquaporin-1 and Osmosis: From Physiology to Precision in... : Journal of the American Society of Nephrology
ion and/or trafficking are key to sustain osmosis in multiple tissues. Here, we review the convergent evidence demonstrating that aquaporin-1 (AQP1) facilitates water transport across endothelial cell...
journals.lww.com
Healthcare staff shortages are on the rise, particularly for #PD nurses. 👉 **Challenging question:** Does offering staff-assisted PD help with nurse shortages? @ispd1.bsky.social @askrenal.bsky.social @nephjc.bsky.social Let's think 🤔 🧵 #NephSky pubmed.ncbi.nlm.nih.gov/34411685/
The Nephrology Nursing Shortage: Insights From a Pandemic - PubMed
The Nephrology Nursing Shortage: Insights From a Pandemic
pubmed.ncbi.nlm.nih.gov
www.linkedin.com/posts/prakas... #AHA24 #CVRM #CVoutcomes #Medsky #Cardiosky #Nephsky
Prakash Gudsoorkar MD, FASN, FNKF on LinkedIn: Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity…
🌟 New Hope for Patients with HFpEF and Obesity: Tirzepatide Shows Promising Results 🌟 Exciting findings from a recent international, randomized trial…
linkedin.com
#AHA24 @ahascience.bsky.social @ahajournals.bsky.social Folks attending AHA -what’s new in hypertension world? -what’s new is heart failure world? Whom to follow for updates?
New @asnkidney.bsky.social Kidney Translation Podcast Genetic Testing in Kidney Disease podcasts.apple.com/us/podcast/j...
www.nejm.org/doi/full/10.... 👉Inebilizumab, a humanized, afucosylated IgG1 kappa monoclonal antibody specifically targets CD19 and results in rapid, deep, and durable B-cell depletion
Inebilizumab for Treatment of IgG4-Related Disease | NEJM
IgG4-related disease is a multiorgan, relapsing, fibroinflammatory, immune-mediated disorder with no approved therapy. Inebilizumab targets and depletes CD19+ B cells and may be effective for treat...
nejm.org
